For patients undergoing a radical cystectomy, staying active before and after surgery is key, Dr. Janet Kukreja explained. For patients with bladder cancer undergoing radical cystectomy (the surgical ...
Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...
PADCEV plus KEYTRUDA is the first and only regimen to improve survival when used before and after standard of care (surgical cystectomy) in cisplatin-ineligible patients with muscle-invasive bladder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results